Folate-decorated chitosan/doxorubicin poly(butyl)cyanoacrylate nanoparticles for tumor-targeted drug delivery

Journal of Nanoparticle Research

Volumn 14, Issue 4, 2012, Pages

  Duan, Jinghua ^a   Liu, Mujun ^a   Zhang, Yangde ^a   Zhao, Jinfeng ^a   Pan, Yifeng ^a   Yang, Xiyun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chitosan poly(butyl cyanoacrylate) nanoparticles; Doxorubicin; Folate receptor; Nanomedicine; Targeting drug delivery

Indexed keywords

CELLS; CHITOSAN; CONTROLLED DRUG DELIVERY; CYTOLOGY; DISEASES; FLUORESCENCE IMAGING; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; SYNTHESIS (CHEMICAL); TUMORS; ZETA POTENTIAL;

CHITOSANPOLY(BUTYL CYANOACRYLATE) NANOPARTICLES; DOXORUBICIN; FLOW CYTOMETRY ANALYSIS; FOLATE RECEPTOR; POLY(BUTYL CYANOACRYLATE); TARGETING DRUG DELIVERIES; TUMOR-TARGETED DRUG DELIVERIES; ZETA POTENTIAL MEASUREMENTS;

TARGETED DRUG DELIVERY;

CHITOSAN; CHITOSAN POLY(BUTYL CYANOACRYLATE) NANOPARTICLE; DOXORUBICIN; DRUG CARRIER; FOLATE RECEPTOR; FOLIC ACID; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG UPTAKE; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84862822539     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-012-0761-4     Document Type: Article

References (41)

1. Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J (2006) Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J Microencapsul 23:582-592 (Pubitemid 44446597)
2. Arias JL, Gallardo V, Gomez-Lopera SA, Plaza RC, Delgado AV (2001) Synthesis and characterization of poly (ethyl-2- cyanoacrylate) nanoparticles with a magnetic core. J Control Release 77:309-321 (Pubitemid 33145482)
3. Behan N, Birkinshaw C, Clarke N (2001) Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerization and particle formation. Biomaterials 22:1335-1344 (Pubitemid 32409955)
4. Cho KC, Kim SH, Jeong JH, Park TG (2005) Folate receptormediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate. Macromol Biosci 5:512-519 (Pubitemid 40933989)
5. Couvreur P, Vauthier C (1991) Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives. J Control Release 17:187-198
6. Cummings J, McArdle CS (1986) Studies on the in vivo disposition of adriamycin in human tumors which exhibit different responses to the drug. Br J Cancer 53:835-838 (Pubitemid 16082043)
7. Douglas SJ, Illum L, Davis SS, Kreuter J (1984) Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles. I: Influence of physicochemical factors. J Colloid Interface Sci 101:149-158 (Pubitemid 14642183)
8. Douglas SJ, Illum L, Davis SS (1985) Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II: Influence of stabilizers. J Colloid Interface Sci 103: 154-163 (Pubitemid 15437410)
9. Duan JH, Zhang YD, Han SW, Chen YX, Li B, Liao MM, Chen W, Deng XM, Zhao JF, Huang BY (2010) Synthesis and in vitro/in vivo anti-cancer evaluation of curcuminloaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 400:211-220
10. Gabizon AT, Horowitz D, Goren D, Tzemach F, Mandelbaum-Shavit M, Qazen M, Zalipsky S (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem 10:289-298 (Pubitemid 29147733)
11. Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A (2000) Nuclear delivery of doxorubicin via folate targeted liposomes with bypass of multidrug-resistance efflux. Clin Cancer Res 6:1949-1957 (Pubitemid 30305094)
12. Gu FX, Karnik R, Wang AZ, Alexis F, Levy-Nissenbaum E, Hong S, Langer RS, Farokhzad OC (2007) Targeted nanoparticles for cancer therapy. Nano Today 2:14-21 (Pubitemid 46672835)
13. Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J (1999) Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 16:1564-1569 (Pubitemid 29510553)
14. Huang CY, Chen CM, Lee YD (2007) Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion. Int J Pharm 338:267-275
15. Illum L, Khan MA, Mak E, Davis SS (1986) Evaluation of carrier capacity and release characteristics for poly(butyl 2-cyanoacrylate) nanoparticles. Int J Pharm 30:17-28 (Pubitemid 16101992)
16. Jain KK (2005) Editorial: targeted drug delivery for cancer. Technol Cancer Res Treat 4:311-313 (Pubitemid 41242607)
17. Juan BSD, Briesen HV, Gelperima SE, Kreuter J (2006) Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays. J Drug Target 14:614-622 (Pubitemid 44712357)
18. Lee R, Low P (1994) Delivery of liposomes into cultured KB cells via folate receptor mediated endocytosis. J Biol Chem 269:3198-3204 (Pubitemid 24237629)
19. Lescure F, Zimmer C, Roy D, Couvreur P (1992) Optimization of polyalkylcyanoacrylate nanoparticle preparation: influence of sulfur dioxide and pH on nanoparticle characteristics. J Colloid Interface Sci 154:77-86
20. Liu L, Zhu XL, Zhang DM, Huang JY, Li GX (2007) An electrochemical method to detect folate receptor positive tumor cells. Electrochem Commun 9:2547-2550 (Pubitemid 47405288)
21. Lu Y, Low PS (2002) Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol Immunother 51:153-162 (Pubitemid 34298111)
22. Lu JY, Lowe DA, Kennedy MD, Low PS (1999) Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. J Drug Target 7:44-53
23. Luten J, Van Steenbergen MJ, Lok MC, De Graaff AM, Van Nostrum CF, Talsma H, Hennink WE (2008) Degradable PEG-folate coated poly(DMAEA-co-BA) phosphazenebased polyplexes exhibit receptor-specific gene expression. Eur J Pharm Sci 33:241-251
24. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271-284 (Pubitemid 30122932)
25. Maksimenko O, Pavlov E, Toushov E, Molin A, Stukalov Y, Prudskova T, Feldman V, Kreuter J, Gelperina S (2008) Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 356: 325-332
26. Malmsten M, Lindman B (1992) Self-assembly in aqueous block copolymer solution. Macromolecules 25:5440-5445 (Pubitemid 23572195)
27. Minko T, Kopeckova P, Pozharov V, Kopecek J (1998) HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Control Release 54:223-233 (Pubitemid 28342701)
28. Monsky WL, Fukumura D, Gohongi T, Ancukiewcz M, Weich HA, Torchilin VP, Yuan F, Jain RK (1999) Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res 59:4129-4135 (Pubitemid 29393588)
29. Nomura T, Koreeda N, Yamashita F, Takakura Y, Hashida M (1998) Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissueisolated tumors. Pharm Res 15:128-132 (Pubitemid 28080879)
30. Peracchia MT, Fattal E, Desmaele D, Besnard M, Noel JP, Gomis JM, Appel MD, Angelo J, Couvreur P (1999) Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J Control Release 60:121-128 (Pubitemid 29255834)
31. Reddy JA, Low PS (2000) Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release 64:27-37 (Pubitemid 30035305)
32. Reddy LH, Sharma RK, Murthy RSR (2004) Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's Lymphoma tumour. J Drug Target 12:443-451 (Pubitemid 39562428)
33. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P (2003) Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 55:519-548 (Pubitemid 36423302)
34. Verdiere CD, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P (1994) Uptake of doxorubicin from loaded nanoparticles in multidrug resistant leukemic murine cells. Cancer Chemother Pharmacol 33:504-508 (Pubitemid 24082346)
35. Wang S, Lee RJ, Cauchon G, Gorenstein DG (1995) Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethyleneglycol. Proc Natl Acad Sci 92:3318-3322
36. Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA (1992) Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 52:6708-6711
37. Yoo HS, Park TG (2001) Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release 70:63-70 (Pubitemid 32144793)
38. Yoo HS, Park TG (2004) Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 100:247-256 (Pubitemid 39491276)
39. Zhang ZR, Liao GT, Nagai T, Hou SX (1996) Mitoxantrone polybutyl cyanoacrylate nanoparticles as an anti-neoplastic targeting drug delivery system. Int J Pharm 139:1-8 (Pubitemid 26276261)
40. Zhang ZP, Lee HS, Feng SS (2007) Folate-decorated poly(lactideco- glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 28:1889-1899
41. Zhang Y, Zhu SY, Yin LC, Qian F, Tang C, Yin CH (2008) Preparation, characterization and biocompatibility of poly(ethylene glycol)-poly(n-butyl cyanoacrylate) nanocapsules with oil core via miniemulsion polymerization. Eur Polym J 44:1654-1661